Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paul L, Underwood"'
Autor:
Wayne B. Batchelor, Stephen G. Ellis, Gregg W. Stone, Anita A. Joshi, Paul L. Underwood, John A. Ormiston, Hong Wang
Publikováno v:
Journal of Interventional Cardiology. 26:49-57
Objectives To assess the influence of race on long-term outcomes following percutaneous coronary intervention (PCI) with paclitaxel-eluting stents (PES). Background Data on the influence of race on long-term outcomes following PCI with drug-eluting s
Autor:
B A Sean Stern, Paul L. Underwood, Stacey L. Amorosi, M.P.H. Greg De Lissovoy Ph.D., Mark A. Turco, Keith D. Dawkins, Anuraag R. Kansal
Publikováno v:
Journal of Interventional Cardiology. 25:353-363
Background: With the changing health care environment, cost effectiveness is an important adjunct to clinical investigation when assessing new medical devices. This study presents an economic model to evaluate cost effectiveness of coronary stents. M
Autor:
Raul Moreno, Keith D. Dawkins, Peter Schwimmbeck, Paul L. Underwood, Martyn Thomas, Gert Richardt, Victor Legrand, Ezio Bramucci, Carlo Briguori, Ralf Birkemeyer, Nikos Werner, Imre Ungi
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 10(11)
The PROMUS™ Element™ European Post-Approval Surveillance Study (PE-Prove) is a prospective, open-label, multicentre observational study designed to assess outcomes following PROMUS Element everolimus-eluting stent implantation in an unselected pa
Autor:
Wayne B, Batchelor, Stephen G, Ellis, John A, Ormiston, Gregg W, Stone, Anita A, Joshi, Hong, Wang, Paul L, Underwood
Publikováno v:
Journal of interventional cardiology. 26(1)
To assess the influence of race on long-term outcomes following percutaneous coronary intervention (PCI) with paclitaxel-eluting stents (PES).Data on the influence of race on long-term outcomes following PCI with drug-eluting stents are limited becau
Autor:
Mark A, Turco, Anuraag R, Kansal, Sean, Stern, Stacey L, Amorosi, Paul L, Underwood, Greg D E, Lissovoy, Keith D, Dawkins
Publikováno v:
Journal of interventional cardiology. 25(4)
With the changing health care environment, cost effectiveness is an important adjunct to clinical investigation when assessing new medical devices. This study presents an economic model to evaluate cost effectiveness of coronary stents.Markov modelin
Autor:
John A, Ormiston, Mark A, Turco, Jack J, Hall, Louis A, Cannon, Steven J, Yakubov, Michael J, Lucca, Gregg W, Stone, Charles D, O'Shaughnessy, Joseph A, Kozina, Ian C, Gilchrist, Barry D, Bertolet, Stephen G, Worthley, Paul L, Underwood, Keith D, Dawkins
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 75(5)
The long-term impact of treating de novo coronary lesions in native vessels and challenging small vessel and long lesion subsets with TAXUS Liberté stents is unknown. This report examines the 3-year efficacy and safety from the TAXUS ATLAS program.T
Publikováno v:
Herz. 26(2)
Coronary artery perforation is a rare but serious complication of percutaneous coronary interventions. Case Report: We report on the treatment of a coronary perforation during percutaneous transluminal coronary angioplasty (PTCA) of the left anterior